Announcements

16 June 2025
Cells | Highly Downloaded Papers in 2023

Cells (ISSN: 2073-4409) is an international, peer-reviewed, open access journal published online semi-monthly by MDPI, providing an advanced forum for studies related to cell biology, molecular biology, and biophysics.

We are pleased to invite you to read the most highly downloaded papers of Cells in 2023.

  1. “A Beginner’s Guide to Cell Culture: Practical Advice for Preventing Needless Problems”
    by Sabine Weiskirchen, Sarah K. Schröder, Eva Miriam Buhl and Ralf Weiskirchen
    Cells 2023, 12(5), 682; https://doi.org/10.3390/cells12050682
    Available online: https://www.mdpi.com/2073-4409/12/5/682
  2. “A Review of Single-Cell RNA-Seq Annotation, Integration, and Cell–Cell Communication”
    by Changde Cheng, Wenan Chen, Hongjian Jin and Xiang Chen
    Cells 2023, 12(15), 1970; https://doi.org/10.3390/cells12151970
    Available online: https://www.mdpi.com/2073-4409/12/15/1970
  3. “The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders”
    by Emilija Knezevic, Katarina Nenic, Vladislav Milanovic and Nebojsa Nick Knezevic
    Cells 2023, 12(23), 2726; https://doi.org/10.3390/cells12232726
    Available online: https://www.mdpi.com/2073-4409/12/23/2726
  4. “Sirtuin 6—A Key Regulator of Hepatic Lipid Metabolism and Liver Health”
    by X. Charlie Dong
    Cells 2023, 12(4), 663; https://doi.org/10.3390/cells12040663
    Available online: https://www.mdpi.com/2073-4409/12/4/663
  5. “The “3Ds” of Growing Kidney Organoids: Advances in Nephron Development, Disease Modeling, and Drug Screening”
    by Brooke E. Chambers, Nicole E. Weaver and Rebecca A. Wingert
    Cells 2023, 12(4), 549; https://doi.org/10.3390/cells12040549
    Available online: https://www.mdpi.com/2073-4409/12/4/549
  6. “Flow Cytometry: The Next Revolution”
    by J. Paul Robinson, Raluca Ostafe, Sharath Narayana Iyengar, Bartek Rajwa and Rainer Fischer
    Cells 2023, 12(14), 1875; https://doi.org/10.3390/cells12141875
    Available online: https://www.mdpi.com/2073-4409/12/14/1875
  7. “Molecular Mechanisms in Autoimmune Thyroid Disease”
    by Hernando Vargas-Uricoechea
    Cells 2023, 12(6), 918; https://doi.org/10.3390/cells12060918
    Available online: https://www.mdpi.com/2073-4409/12/6/918
  8. “Spatial Transcriptomic Technologies”
    by Tsai-Ying Chen, Li You, Jose Angelito U. Hardillo and Miao-Ping Chien
    Cells 2023, 12(16), 2042; https://doi.org/10.3390/cells12162042
    Available online: https://www.mdpi.com/2073-4409/12/16/2042
  9. GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    by Ka Young Kim, Ki Young Shin and Keun-A Chang
    Cells 2023, 12(9), 1309; https://doi.org/10.3390/cells12091309
    Available online: https://www.mdpi.com/2073-4409/12/9/1309
  10. “In Vitro Human Haematopoietic Stem Cell Expansion and Differentiation”
    by Yavor K. Bozhilov, Ian Hsu, Elizabeth J. Brownand Adam C. Wilkinson
    Cells 2023, 12(6), 896; https://doi.org/10.3390/cells12060896
    Available online: https://www.mdpi.com/2073-4409/12/6/896
  11. “CRISPR-Cas System: The Current and Emerging Translational Landscape”
    by Narendranath Bhokisham, Ethan Laudermilch, Lindsay L. Traeger, Tonya D. Bonilla, Mercedes Ruiz-Estevez and Jordan R. Becker
    Cells 2023, 12(8), 1103; https://doi.org/10.3390/cells12081103
    Available online: https://www.mdpi.com/2073-4409/12/8/1103
  12. “Recent Advances in CAR-Based Solid Tumor Immunotherapy”
    by Min Hwa Shin, Eunha Oh, Yunjeong Kim, Dae-Hwan Nam, So Young Jeon, Jin Hyuk Yu and Dohsik Minn
    Cells 2023, 12(12), 1606; https://doi.org/10.3390/cells12121606
    Available online: https://www.mdpi.com/2073-4409/12/12/1606
  13. “HIV–Host Cell Interactions”
    by Sepiso K. Masenga, Bislom C. Mweene, Emmanuel Luwaya, Lweendo Muchaili, Makondo Chona and Annet Kirabo
    Cells 2023, 12(10), 1351; https://doi.org/10.3390/cells12101351
    Available online: https://www.mdpi.com/2073-4409/12/10/1351
  14. “Current State and Future Directions in the Therapy of ALS”
    by Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt and Meret Herdick
    Cells 2023, 12(11), 1523; https://doi.org/10.3390/cells12111523
    Available online: https://www.mdpi.com/2073-4409/12/11/1523
  15. “Slowing the Progression of Diabetic Kidney Disease
    by Olivia Blazek and George L. Bakris
    Cells 2023, 12(15), 1975; https://doi.org/10.3390/cells12151975
    Available online: https://www.mdpi.com/2073-4409/12/15/1975
  16. “Liquid Biopsy in Neurological Diseases”
    by Sunny Malhotra, Mari Carmen Martín Miras, Agustín Pappolla, Xavier Montalban and Manuel Comabella
    Cells 2023, 12(14), 1911; https://doi.org/10.3390/cells12141911
    Available online: https://www.mdpi.com/2073-4409/12/14/1911
  17. “Current Strategies for Exosome Cargo Loading and Targeting Delivery”
    by Haifeng Zeng, Shaoshen Guo, Xuancheng Ren, Zhenkun Wu, Shuwen Liu and Xingang Yao
    Cells 2023, 12(10), 1416; https://doi.org/10.3390/cells12101416
    Available online: https://www.mdpi.com/2073-4409/12/10/1416
  18. “The Role of TP53 in Adaptation and Evolution”
    by Konstantinos Voskarides and Nefeli Giannopoulou
    Cells 2023, 12(3), 512; https://doi.org/10.3390/cells12030512
    Available online: https://www.mdpi.com/2073-4409/12/3/512
  19. “The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target”
    by William W. Feng, Hannah T. Zuppe and Manabu Kurokawa
    Cells 2023, 12(12), 1605; https://doi.org/10.3390/cells12121605
    Available online: https://www.mdpi.com/2073-4409/12/12/1605
  20. “Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation”
    by Flora Tassone, Dragana Protic, Emily Graves Allen, Alison D. Archibald, Anna Baud, Ted W. Brown, Dejan B. Budimirovic, Jonathan Cohen, Brett Dufour, Rachel Eiges et al.
    Cells 2023, 12(18), 2330; https://doi.org/10.3390/cells12182330
    Available online: https://www.mdpi.com/2073-4409/12/18/2330

More articles published in Cells can be accessed via https://www.mdpi.com/search?journal=cells.

3 June 2025
MDPI INSIGHTS: The CEO's Letter #23 - MDPI Summits Spain & Italy, Ei Compendex, and Editorial Independence

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Highlights from the MDPI Spain Summit in Barcelona (21-22 May)

In May we hosted the MDPI Spain Summit in Barcelona – our second summit in the city following the inaugural one in November 2023.


Stefan Tochev (CEO, MDPI) at the MDPI Spain Summit in Barcelona, 22 May 2025.

Creating a space for exchange of views

The goal of our summits is to bring together Chief Editors of MDPI journals from across disciplines and institutions. These intimate gatherings provide a platform to present the latest developments at MDPI and to initiate open conversations about our journals, the future of open access, and the evolving landscape of scientific publishing.

Most importantly, these are opportunities for in-person connection, providing a more meaningful space for the exchange of views and for building long-term relationships.

Exploring the future of scientific publishing in Spain

The summit took place on 21–22 May and featured a mix of MDPI presentations (including two guest presentations), roundtable discussions, and Q&A sessions. On the first day, we held a focused session with our Chief Editors to gather feedback and have open discussions on their journal development, the peer-review process, and local accreditation systems.


Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI, presents MDPI’s Editorial Process and Peer Review Quality Metrics at the MDPI Spain Summit in Barcelona, 22 May 2025.

I had the pleasure of opening the Summit with a welcome address and an overview of MDPI’s recent milestones. The agenda then included the following sessions:

  • MDPI and Recent Developments in the Spanish Market – Dr. Marta Colomer (Public Affairs Specialist, MDPI)
  • MDPI Editorial Process and Peer Review Quality Metrics – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Open Access in Spain – Dr. Remedios Melero (Researcher, CSIC – guest speaker)
  • AI in Publishing and MDPI's Actions – Dr. Enric Sayas (Business Analyst, MDPI), Daniele Raimondi (Data Scientist, MDPI), and Dr. Alexandre López-Borrull (Researcher, Universitat Oberta de Catalunya – guest speaker)
  • Publication Ethics – Ana Stankovic (Research Integrity and Publication Ethics, MDPI)
  • Opening and Closing remarks were provided by Rocksy Zhang (Editorial Director, MDPI)

We are extremely grateful for the strong engagement shown by our Editors, who were clearly appreciative of the event and the discussions we had. They felt seen and heard, which is a vital prerequisite for building open channels of communication and cultivating productive long-term collaborations.


MDPI colleagues during MDPI Spain Summit in Barcelona (22 May 2025).

A big thank-you to the entire Barcelona team for organizing such a successful event!

Upcoming MDPI Summit events:

  • Italy Summit – Rome (26–27 May)
  • US Summit – Boston, MA (5–6 June)
  • France Summit – Paris (12–13 June)
  • US Summit – Houston, TX (26–27 June)
  • UK Summit – London (16–17 September)
  • Germany Summit – Berlin (18–19 September)
  • Romania Summit – Bucharest (23–24 October)
    ...with more in between, and more to follow.

Impactful Research

50 MDPI Journals Now Indexed in Ei Compendex

Indexing is a key indicator of a journal’s scientific impact. An indexed journal gives research greater visibility and credibility within the global academic community and is recognized for its quality and relevance. While many of our journals are included in major databases such as Web of Science and Scopus, MDPI also places strong emphasis on journal inclusion in subject-specific indexing platforms that align with each journal’s scope. This ensures that when you publish with MDPI, you publish with impact.

I’m pleased to share that as at May 2025, 51 of our journals are now indexed in Ei Compendex, a leading bibliographic database for engineering and applied sciences. This is a major milestone that reflects both the quality or our editorial processes and the relevance of the research we publish in these fields.

“When you publish with MDPI, you publish with impact”

Discoverability and reach

Inclusion in Ei Compendex means greater discoverability for our authors and broader reach of our journals in the fields of engineering and technology. It improves our ability to support global research and innovation, while building MDPI’s reputation in the applied sciences. This recognition is the result of the dedicated work of our editorial teams, reviewers, and authors, and of our overall commitment to excellence in publishing.

You can read our full announcement here.

Appreciative thanks to everyone involved in reaching this milestone.

Inside MDPI

 

One Year of MDPI’s Seoul Office

On 29 April, we marked one year since the opening of our Seoul office, MDPI’s first local hub in South Korea. South Korea is a key market for MDPI, currently ranking as our sixth-largest contributor to the company’s total publications, with over 89,000 MDPI articles authored by individuals affiliated with Korean institutions. Over the past 12 months, the Seoul team has made great strides in building our visibility, networks, and presence in the region.

A few highlights from the past year


Claude Seo (MDPI Korea Office Manager, Seoul)

Claude Seo, who has over 15 years of experience in the academic publishing industry, is the Office Manager of the Seoul office.

In its inaugural year, the Seoul office focused primarily on marketing and promotional activities to support the MDPI brand locally. During that time, the team concentrated on scholar visits to local institutions, attending academic conferences, and hosting editorial board meetings.

The team also secured 10 Institutional Open Access Program (IOAP) renewals, signed three new IOAP agreements, and established one new Society affiliation.

The Seoul office also hosted its first library book fair and reached over 1,000 followers on its LinkedIn channel, which is an encouraging indication of local visibility and engagement.

“The Seoul team has made strides in building our visibility, networks, and presence in the region”

Growth plans

Later this year, we are working on opening a new Seoul office in a more central location, with room for our growing team. The new space will bring us closer to other publishing partners and provide easier access to and from the airport. The Seoul office will continue to expand its efforts in outreach and engagement as its builds its presence in South Korea.

Warm thanks to the entire Seoul team for their hard work and dedication, and to all MDPI colleagues who have contributed to this exciting chapter in our global journey.

Coming Together for Science

Highlights from the MDPI Italy Summit in Rome (26–27 May)

We closed the month of May by hosting the first MDPI Italy Summit in Rome. This was an important event for us, as Italy has consistently ranked among the top ten countries globally for open access publications over the past decade.

MDPI and Italy: Facts & Figures

  • With over 144,000 publications (as at 31 May 2025), Italy is MDPI’s third largest contributor after China and the USA.
  • In 2024, MDPI was the second-largest publishing house in Italy.
  • The 7,165 Editorial Board Members (EBMs) drawn from Italian institutions represent 8.9% of all MDPI academic editors.
  • Among these, 319 serve as Editors-in-Chief (EiCs) or Section Editors-in-Chief (SEiCs).
  • Eleven Italian EBMs were recognized as 2024 Clarivate Highly Cited Researchers.
  • In 2024, MDPI received 24,873 review reports and collaborated with 88,578 reviewers from Italy.
  • 23,131 Guest Editors from Italian institutions led 4,827 Special Issues across 248 MDPI journals.
  • MDPI partners with over 900 institutions globally, of which 17 are in Italy.

The MDPI Italy Summit in Rome


Dr. Prof. Giulio Cerullo, EiC of Applied Sciences, at the MDPI Italy Summit in Rome (27 May 2025).

Held on 26–27 May, the MDPI Italy Summit brought together 25 Chief Editors from across our journal portfolio, including some of our largest journals such as Applied Sciences, to discuss MDPI’s latest developments and collaborations in the Italian market, our use of data intelligence and AI to support strategic decision-making, a look into our editorial process, peer-review quality metrics, and conversations around research integrity and community engagement.

The Summit featured MDPI presentations followed by Q&A and concluded with a roundtable discussion. On the evening of the 26th, we hosted a dinner with our Editors to connect personally, learn more about their research, and hear feedback on journal operations and the broader academic landscape in Italy.


Gathering of Editors-in-Chief and MDPI staff at the MDPI Italy Summit in Rome (27 May 2025).

Event Agenda – 27 May

Moderated by Maddalena Favaretto (Conference Scientific Advisor, MDPI), the program featured:

  • MDPI Overview, Achievements, Latest News and Future Developments – Stefan Tochev (CEO, MDPI)
  • Country Report: Italy – Dr. Laura Perez Martin (Conference Assistant, MDPI)
  • AI in Publishing and MDPI’s Actions – Dr. Andrea Perlato (Head of Data Analytics, MDPI)
  • MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Panel Discussion – Stefan, Andrea, Giulia


Panel Discussion with Stefan Tochev (CEO, MDPI), Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI), Dr. Andrea Perlato (Head of Data Analytics, MDPI) during the MDPI Italy Summit in Rome (27 May 2025).

A big thank-you to our Conference team and everyone who worked behind the scenes to make these events run smoothly.

Closing Thoughts

Upholding Editorial Independence in Scholarly Publishing

A recent MDPI blog post written by Dr. Ioana Craciun (Scientific Communications Specialist, MDPI), “Editorial Independence and Publisher Support: Collaborating to Uphold Integrity,” highlights the important balance between editorial autonomy and publisher collaboration in academic publishing.

As the leading fully Open Access scholarly publisher, we are proud to champion editorial independence within our publishing process.

Drawing from the Committee on Publication Ethics (COPE) guidelines, the article emphasizes that while editors must have the freedom to make decisions based on scholarly merit, publishers play a critical role in providing the necessary infrastructure and tools to support the editorial process. This collaborative approach ensures the integrity of the peer review process, builds trust among authors and readers, and upholds the quality and relevance of published content.

MDPI highlights its commitment to this model by investing in research integrity specialists, AI tools for plagiarism detection, and administrative support, all aimed at empowering editors to make independent, informed decisions.

Stefan Tochev
Chief Executive Officer
MDPI AG

20 May 2025
Meet Us at the 56th Symposium of the Polish Society of Histochemists and Cytochemists, 28–31 May 2025, Olsztyn, Poland


Conference: The 56th Symposium of the Polish Society of Histochemists and Cytochemists
Organizer: Polish Society of Histochemists and Cytochemists
Date: 28–31 May 2025
Place: Hotel Anders, ul. Spacerowa 2, 14-133 Stare Jabłonki, Poland

MDPI journals will be exhibitors at PHTC 2025, which will be held in Olsztyn, Poland, from 28 to 31 May 2025.

The 56th Symposium, titled “From the Silver to Dream—Histochemistry is Good for Everything,” is organized by the Olsztyn Branch of the Polish Society of Histhoms and Cytochemists.

The following MDPI journals will be represented:

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://pthc2025.pl/.

13 May 2025
Empowering Academic Growth with MDPI: A Scientific Publishing Exchange at Toronto Metropolitan University, 15 May 2025


MDPI is excited to collaborate with Toronto Metropolitan University to host an engaging Scientific Publishing Workshop aimed at empowering scholars with the knowledge and tools needed to succeed in academic publishing. This workshop will delve into the key aspects of MDPI’s open access publishing framework, offering an in-depth exploration of journal selection, the editorial workflow, and the essentials of publication ethics. Participants will also gain practical advice on improving their scientific writing and effectively addressing reviewer comments, with guidance from an experienced professional. This session promises to equip attendees with valuable skills to elevate their publishing journey.

Workshop Highlights:

  • Learn How to Better Write and Structure a Research Article;
  • How to Choose Where to Publish Academic Work;
  • How to Respond to Reviewer Comments;
  • Reasons for Rejection During Pre-Check;
  • How to Navigate Through Ethics and AI Use.

Date: 15 May 2025
Time: 12:00–1:30 p.m.
Venue: Toronto Metropolitan University

Program:

Speakers

Program and Content

Time

Dr. Stephen Mora

Introduction to MDPI

12:00–12:05 p.m.

 

How to Write and Structure a Research Article

12:05–12:45 p.m.

 

How to Respond to Reviewer Comments

12:45–1:30 p.m.

Dr. Stephen Mora has an M.Sc. and Ph.D. in kinesiology and health science from York University, Canada. He started working at MDPI in May 2024 and is now the Managing Editor of IJOM, a newly transferred society journal published by MDPI. During his graduate studies and MDPI tenure, Stephen has gained extensive experience in attending conferences, meeting with scholars, and hosting online and in-person presentations.

7 May 2025
Cells Exceptional Reviewers List 2025


We are thrilled to share the updated Exceptional Reviewers List 2025. This program was designed to recognize and honor scholars who have delivered consistently exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Cells (ISSN: 2073-4409) recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. We thank our pool of excellent reviewers.

We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in Cells’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.

The Exceptional Reviewers List was introduced in May 2025. Each quarter, we will be selecting a group of outstanding reviewers and introducing them here.

Q1

Name: Dr. Wei Wen Lim
Affiliation: National Heart Research Institute Singapore, National Heart Centre Singapore, 169609, Singapore
Name: Prof. Dr. Jae-Wook Oh
Affiliation: Department of Stem Cell and Regenerative Biotechnology, KIT, Konkuk University, Seoul, Republic of Korea
Name: Dr. Giovanna Liguori
Affiliation: Institute of Genetics and Biophysics Adriano Buzzati Traverso, Naples, Italy
Name: Dr. Yoichi Ezura
Affiliation: Department of Molecular Pharmacology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan
Name: Dr. Bruno Brando
Affiliation: Hematology Laboratory and Transfusion Center, Legnano General Hospital, 20025 Legnano (Milano), Italy
Name: Dr. Benoit Miotto
Affiliation: Team Epigenetics and Nuclear Functions in Human Diseases, Université Paris Cité, Institut Cochin, INSERM U1016, CNRS UMR8104, F-75014 Paris, France
Name: Dr. Yongqing Liu
Affiliation: Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, KY, USA
Name: Dr. Tomaž Büdefeld
Affiliation: Centre for Human Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, 2000 Maribor, Slovenia
Name: Dr. Cláudia Saraiva
Affiliation: INSERM-Université Bourgogne U1231, Equipe GAD Génétique des Anomalies du Développement, Dijon, France
Name: Prof. Dr. Gundula Schulze-Tanzil
Affiliation: Institute of Anatomy and Cell Biology, Paracelsus Medical University, Nuremberg and Salzburg, 90419 Nuremberg, Germany
Name: Dr. Abhishek Tyagi
Affiliation: Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
Name: Dr. Riya Thomas
Affiliation: Seattle Children's Research Institute, 1900 9th Ave, Seattle, WA 98101, USA
Name: Prof. Dr. Mirko Manetti
Affiliation: Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Florence, Italy
Name: Prof. Dr. Giuseppe Biagini
Affiliation: Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41100 Modena, Italy
Name: Dr. Wenjing Zhang
Affiliation: Department of Pathology, College of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA
Name: Dr. Mary Gilbert
Affiliation: Office of Research and Development, Center for Public Health and Environmental Assessment, US Environmental Protection Agency, Research Triangle Park, NC 27709, USA
Name: Dr. Sudeep Kumar
Affiliation: Cincinnati Children’s Hospital Medical Center 3333 Burnet Ave Cincinnati, OH 45229, USA
Name: Dr. Christine Hellweg
Affiliation: Department of Radiation Biology, Institute of Aerospace Medicine, German Aerospace Center (DLR), 51147 Cologne, Germany
Name: Dr. Ignacio Torrecilla
Affiliation: Department of Oncology, University of Oxford: Oxford, Oxfordshire, UK
Name: Prof. Dr. Margaret L. Britz
Affiliation: Tasmanian Institute of Agriculture, University of Tasmania, Hobart, TAS 7005, Australia
Name: Dr. Sarath Babu Nukala
Affiliation: Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Name: Dr. Jezabel Rodriguez-Blanco
Affiliation: Darby Children’s Research Institute, Hollings Cancer Center, Medical University of South Carolina, Miami, USA
Name: Dr. Phillip Domeier
Affiliation: Department of Microbiology and Immunology, University of British Columbia: Vancouver, British Columbia, Canada
Name: Dr. Jose Rodriguez-Alvarez
Affiliation: Department Bioquímica i Biologia Molecular, Institut de Neurociències, Universitat Autònoma de Barcelona, 08193 Cerdanyola del Vallès, Spain
Name: Dr. Michał Zarobkiewicz
Affiliation: Department of Clinical Immunology, Medical University of Lublin, Lublin, Poland
Name: Dr. Béla Papp
Affiliation: Institut National de la Santé et de la Recherche Médicale, Inserm UMR 1342, Institut de Recherche Saint-Louis, Hôpital Saint-Louis, Paris, France
Name: Dr. Kristina Pilipović
Affiliation: Faculty of Medicine, University of Rijeka, Rijeka, Croatia
Name: Prof. Dr. Johannes Boltze
Affiliation: School of Life Sciences, University of Warwick, Coventry CV4 7AL, UK
Name: Dr. Harinarayanan Janakiraman
Affiliation: Michael DeBakey Department of Surgery, Baylor College of Medicine, Houston TX 77030, USA
Name: Dr. Qing Jun Wang
Affiliation: College of Medicine, University of Kentucky, Lexington, KY 40536, USA

See what our reviewers say about the review process of Cells:

The review process is well organized and straightforward. The professional editorial team provides tremendous support, making it a good experience for reviewers and authors alike.”—Prof. Dr. Johannes Boltze

In the era of AI-powered generators, the revision undertaken by independent reviewers based on their prior work experience and accumulated knowledge is paramount to ensure the sustained flourishing of the research community.”—Dr. Tomaž Büdefeld

As a retired senior academic, I have the time and experience to add value to the peer-review processes. It is a duty that requires considerable effort, to spot the gems as well as the glitches, by thorough analysis of data and checking all claims based on data and the literature cited. It is also a two-way conversation aimed at improving the submitted manuscripts so that any resulting publication enriches our knowledge through accurate reporting. I gain a lot out of this and hope my well-meant feedback adds value.”—Prof. Dr. Margaret L. Britz

Reviewing for Cells is guided by a comfortable platform: Cells addresses emerging fields. Hence, I benefit by updating my scientific point of view and I feel that my comments are generally addressed.”—Prof. Dr. Gundula Schulze-Tanzil

Q2

Name: Prof.Dr. Francis William Luscinskas
Affiliation: Harvard Medical School
NRB, Room 752P
77 Avenue Louis Pasteur, Boston, MA 2115, USA
Name: Dr. Matthias Nees
Affiliations: 1 Department of Biochemistry and Molecular Biology, Medical University in Lublin, ul. Chodzki 1, 20-093 Lublin, Poland;
2 Institute of Biomedicine and Western Cancer Centre FICAN West, University of Turku, 20101 Turku, Finland
Name: Prof. Dr. Maria Quetglas-Llabrés
Affiliation: Health Research Institute of Balearic Islands (IdISBa), 07120 Palma de Mallorca, Spain
Name: Dr. Amber Mills
Affiliation: University of Pittsburgh, USA
Name: Dr. Kim Keeling
Affiliation: Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States
Name: Dr. Hengrui Liu
Affiliation: The University of Cambridge, UK
Name: Prof. Dr. Justin C. Konje
Affiliation: Department of Health Sciences, University of Leicester, Leicester LE1 7RH, UK
Name: Dr. Shizue Mito
Affiliation: Department of Medical Education, School of Medicine, University of Texas Rio Grande Valley, Edinburg, TX 78541, USA
Name: Dr. Victor Manuel González Suárez
Affiliation: Department of Electrical Engineering, University of Oviedo, Gijón 33204, Spain
Name: Prof. Dr. Anna Silvia Pistocchi
Affiliation: Università degli Studi di Milano, Dipartimento di Biotecnologie Mediche e Medicina Traslazionale, Via Viotti, 3/5, 20133, Milano, Italy
Name: Prof.Dr. Ken-ichi Sato
Affiliation: Department of Molecular Biosciences, Faculty of Life Sciences, Kyoto Sangyo University, Kamigamo-Motoyama, Kita-ku, Kyoto, Japan
Name: Dr. Quentin Lemaire
Affiliation: Univ. Lille, CNRS, UMR 8576—UGSF—Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France
Name: Dr. Jason Stumhofer
Affiliation: University of Arkansas for Medical Sciences, USA
Name: Dr. Roberta Palmour
Affiliation: Department of Human Genetics, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 0C7, Canada
Name: Dr. Anthony Pedley
Affiliation: Department of Biochemistry and Molecular Biology Carver College of Medicine, The University of Iowa, USA
Name: Dr. Yangluowa Qu
Affiliation: Ocular Surface Center, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA
Name: Dr. Valentyn Oksenych
Affiliation: University of Bergen, 5020 Bergen, Norway
Name: Dr. Gaskon Ibarretxe
Affiliation: University of the Basque Country (UPVEHU)
Faculty of Medicine and Nursing
Cell Biology and Histology Department
Barrio Sarriena sn, 48940, Leioa, Spain
Name: Dr. Timothy Keiffer
Affiliation: LSU Health Shreveport, USA
Name: Prof. Dr. Hitoshi Sawada
Affiliations: 1 Professor, Department of Food and Life Environment, College of Human Life and Environment, Kinjo Gakuin University, Moriyama-ku, Nagoya, Japan;
2 Emeritus Professor, Nagoya University, chikusa-ku, Nagoya, Japan
Name: Dr. Jens Schuster
Affiliation: Uppsala Universitet, Uppsala, Sweden
Name: Dr. Paulina Tokarz
Affiliation: Department of Molecular Genetics, Faculty of Biology and Environmental Protection, The University of Lodz, Łódź, Poland
Name: Prof. Dr. Lucie Germain
Affiliation: Department of Surgery, Faculty of Medicine, Université Laval, Québec, QC G1V 0A6, Canada. Regenerative Medicine Division, CHU de Québec—Université Laval Research Centre, Québec, QC G1J 1Z4, Canada Université Laval Research Center on Experimental Organogenesis/LOEX, Québec, QC G1J 1Z4, Canada
Name: Dr. Lenka Stixova
Affiliation: Academy of Sciences of the Czech Republic, Department of Molecular Cytology and Cytometry, Prague, Czech Republic
Name: Dr. Gerasimos Daras
Affiliation: Agricultural University of Athens, Department of Biotechnology, Athens, Greece
Name: Prof. Dr. Rita Payan-Carreira
Affiliation: Department of Veterinary Medicine, School of Sciences and Technology, and CHRC-Comprehensive Health Research Centre, University of Évora, Portugal
Name: Dr. Carlos Rossa Junior
Affiliation: Universidade Estadual Paulista "Júlio de Mesquita Filho"disabled, Sao Paulo, Brazil
Name: Dr. Nerea Cuesta-Gomez
Affiliation: Alberta Diabetes Institute, Edmonton, Canada
Name: Dr. Yohannes Woubishet Woldeamanuel
Affiliation: Mayo Clinic Arizona; Ex-Amplify Therapeutics, USA
Name: Dr. John Woulfe
Affiliation: L'Hôpital d'Ottawa, Ottawa, Canada

See what our reviewers say about the review process of Cells:

I work in the Cell Biology and Histology Department of EHU in Spain. I would not say I am a particularly harsh reviewer. When I perceive an honest, well-minded effort on the part of authors to address the concerns involved, provided there are not particularly serious methodological or conceptual issues, I usually give them a chance to get their manuscript published.”—Dr. Gaskon Ibarretxe

It was a pleasure to evaluate Cells articles.”—Prof. Dr. Lucie Germain

Engaging in review processes stimulates my curiosity about cellular and physiological mechanisms while keeping me current with emerging developments and methodological advances in my field of expertise.”—Prof. Dr. Rita Payan-Carreira

Reviewing is a way to uphold the quality and integrity of science, while staying engaged with the latest discoveries and supporting fellow researchers in the field. I appreciate the opportunity and look forward to continuing to contribute to Cells.”—Dr. Nerea Cuesta-Gomez

I am honored to be recognized by Cells for my peer-review contributions. Reviewing cutting-edge research in circadian medicine and biomarkers is rewarding, and I am committed to advancing scientific rigor.”—Dr. Yohannes Woubishet Woldeamanuel

Read more testimonials at https://www.mdpi.com/testimonials?type=all&journal_id=32&page_count=20.

6 May 2025
Meet Us at the Chinese Society of Plant Physiology and Plant Molecular Biology 2025 Annual Meeting, 28 July–1 August 2025, Heilongjiang, China


Conference: Chinese Society of Plant Physiology and Plant Molecular Biology 2025 Annual Meeting
Organization: Chinese Society of Plant Biology
Date: 28 July–01 August 2025
Place: Heilongjiang, China

MDPI journals will be present as exhibitors at the Chinese Society of Plant Physiology and Plant Molecular Biology 2025 Annual Meeting, which will be held at the Sheraton Harbin Xiangfang Hotel, Heilongjiang, China, from 28 July to 1 August 2025.

This conference will cover the following topics:

  1. Plant metabolism and nutritional health;
  2. Plant development and cell fate;
  3. Plant carbon sink and physiological ecology;
  4. Phytoremediation biology and sustainable agriculture;
  5. Plant adversity perception and trait plasticity;
  6. Plant–microbe symbiosis and nutrition;
  7. Crop molecular design breeding;
  8. Plant–biotic interactions and crop disease and pest resistance;
  9. Plant epigenetics;
  10. Interdisciplinary forum;
  11. Young scholars forum;
  12. Youth forum on natural product biosynthesis;
  13. Young scholars’ growth and journal development forum.

The following MDPI journals will be represented:

If you will be attending this conference, please feel free to visit our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.

4 May 2025
Meet Us at the First International Organoid Conference (ISFO 2025), 9–10 May 2025, Shanghai, China


The First International Organoid Conference (ISFO 2025) is the first congress held by the Internation Society for Organoid (ISFO), which is dedicated to unique advantages in various interdisciplinary fields around organoids, such as disease modeling, clinical immunology, pharmacotoxicology, regenerative medicine and is poised to be one of the most promising research tools for clinic studies and drug development.

The following MDPI journals will be represented at the conference:

If you are planning to attend the conference mentioned above, please feel free to start an online conversation with us. Our delegates look forward to meeting you in person at booth #29 and answering any questions you may have.

For more information about the conference, please visit the following website: https://www.isorganoid.org/programs/details/26/6.html.

30 April 2025
MDPI INSIGHTS: The CEO's Letter #22 - 300 Journals in WoS, Norway & Sweden Consortiums, Self-citations

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Over 300 MDPI Journals are Indexed in Web of Science

Indexing is essential to scholarly publishing as it promotes visibility and the impact of research. I’m excited to share that MDPI now has over 300 journals indexed in the Web of Science (WoS). This milestone reflects the work of our authors, editors, reviewers, and the entire MDPI staff, contributing to greater visibility and impact for open access research.

Publish with MDPI, publish with impact.

Having over 300 MDPI journals indexed in the Web of Science is more than a numbers game. It represents a recognition of the quality, consistency, and relevance of the research published in our journals. For the academic community, it reflects the growing trust in MDPI as a reputable publisher, leading the way in open access publishing.

A closer look at the achievement

Being indexed in the WoS nvolves meeting a list of quality criteria, including 24 quality benchmarks for ESCI journals. 

For MDPI, rigorous editorial standards and scientific integrity are key. These enabled over 300 journals to pass the Web of Science quality criteria for indexing.

Here we share a blog post discussing the importance of this milestone for MDPI and open scholarly research. In this post, Constanze Schelhorn, Head of Indexing, at MDPI, and Giulia Stefenelli, Scientific Communications Lead, share their thoughts and insights on what this achievement means for our commitment to high-quality research.

“MDPI has a well-structured quality assurance framework that applies to all our journals. We also apply clear, standardized peer-review policies across our portfolio, ensuring transparency and consistency.” – Constanze Schelhorn, Head of Indexing

“This achievement is a step forward for Open Access research, reinforcing the mission to share scientific knowledge globally and facilitate research progress.” – Giulia Stefenelli, Scientific Communications Lead

Read the blog here: https://blog.mdpi.com/2025/04/03/300-mdpi-journals/

Looking to the future

This milestone is a testament to MDPI’s dedication to peer review, editorial excellence, and innovation in academic publishing. It highlights our role as leaders in open access publishing.

Personally, I see this as just the beginning. We will continue to support researchers, expand our contributions to scholarly communication, and push the boundaries of academic publishing.

Impactful Research

Nearly 920 partner institutions in MDPI’s Institutional Open Access Program

I’m pleased to share some exciting progress from MDPI's Institutional Open Access Program (IOAP), which now includes nearly 920 partner institutions worldwide. This is more than just a number. It reflects the growing trust and collaboration we’ve built with universities, libraries, and research organizations across the globe. 

The IOAP offers institutions discounted Article Processing Charges (APCs), access to a dedicated institutional dashboard, and transparency throughout the publishing process.

Norway’s Sikt Consortium Renews national agreement with MDPI

MDPI has renewed its national agreement with the Sikt Consortium, which now supports 36 institutions across Norway. New partners, such as Kristiania University of Applied Sciences, join long-standing collaborators such as NTNU, the University of Bergen, and UiT, The Arctic University of Norway. The agreement promotes affordable, high-quality open access publishing through centralized APC funding, and reinforces Norway’s leadership in open science.

These agreements reflect MDPI’s mission to remove barriers to scientific publishing and make research freely available to all. By collaborating with national consortia and institutions, we advance the open access and strengthen our global network and collaborations.

Our IOAP Team

A big thank-you to our IOAP team for driving these important collaborations. Their work includes increasing MDPI’s visibility in scholarly communications, strengthening relationships with IOAP partners, and building trust with key stakeholders.

These efforts not only help researchers to publish their work openly and affordably but also reinforce MDPI’s position as a trusted leader in open access.

What are the benefits of MDPI’s IOAP?

For Authors: Researchers affiliated with IOAP partner institutions benefit from automatic discounts on APCs, Book Processing Charges (BPCs), JAMS, and Author Services across MDPI’s journals. The process is seamless as there is no need for codes or special applications. The publishing experience is smoother and more affordable, and centralized invoicing helps simplify the process, allowing authors to focus on their research rather than administration.

For Libraries: Participating libraries receive access to a dedicated institutional dashboard with live metadata on submissions from affiliated authors, past and present. They also benefit from flexible invoicing options (direct, collective, or prepayment) to help streamline administration, while clear, transparent agreements ensure that there are no hidden clauses or small print. Automated deposits into Institutional Repositories further reduce manual work, supporting libraries in their mission to advance open access and serve their research communities.

Inside MDPI

MDPI Self-citation study shows industry alignment

Earlier this month, Dr. Giulia Stefenelli and Dr. Enric Sayas published a thoughtful and transparent article on the ALPSP blog, presenting a self-citation analysis across MDPI’s 237 journals indexed in the Journal Citation Reports (JCR).

They found that MDPI's average self-citation rate in 2024 was 14.85%, well within industry norms and ranking 6th among the top ten publishers. Only 2.3% of MDPI journals were identified as outliers with high self-citation rates, compared to 4.7% among other leading publishers. An alternative approach, using weighted average by publication volume, shows MDPI’s self-citation rate rises from 14% to 19.7%, shifting our rank from 6th to 3rd. The study also shows that the impact of self-citation on journal quartile placement is minimal.

Read the full article on the ALPSP blog: https://blog.alpsp.org/2025/03/mdpi-self-citations-study-highlights.html

Why is this important?

As explained in the full article, the results “reinforce the fact that self-citations have minimal influence on MDPI journal rankings, emphasizing the integrity of editorial practices and the absence of any deliberate efforts to manipulate impact.”

Self-citation is a hot topic, and MDPI is sometimes unfairly singled out in this area. This analysis helps put some perspective to that narrative.

At MDPI, we are committed to transparency and to using data-driven insights to address common misconceptions about open access publishing. Our focus on self-citation reflects this commitment, and we plan to extend our efforts to other areas where the Gold OA model is often misunderstood.

About the authors

Dr. Giulia Stefenelli, Scientific Communications Lead, leverages her expertise in science communication, editorial processes, and Open Access (OA) promotion to address both institutional and country-specific challenges. She collaborates with teams across PR, Editorial Procedures, Institutional Partnerships, Research Integrity, AI and more, developing strategies to engage stakeholders, including policymakers, academics, and industry leaders. Her responsibilities include enhancing MDPI’s scientific network and promoting OA initiatives at events worldwide, supporting the efforts of various departments, and ensuring effective communication to both specialist and broader audiences.

Dr. Enric Sayas is a Business Analyst specializing in the integration of AI and Machine Learning in scientific publishing.

Within MDPI’s AI team, Enric combines his editorial expertise with his passion for AI to support the development of AI-driven solutions tailored to editorial needs, enhancing efficiency and improving decision-making.

Enric’s interests extend to data science methodologies applied to scientific publishing, as well as the broader impact of AI on open science, peer review, and the future of scientific publishing.

Coming Together for Science

 

Plants 2025: From Seeds to Food Security


Prof. Dr. Dilantha Fernando presenting at Plants 2025 in Barcelona, Spain.

The MDPI Conference Plants 2025: From Seeds to Food Security took place in Barcelona, Spain, from 31 March to 2 April 2025.

It was chaired by Editor-in-Chief of MDPI journal Plants (Q1 journal); Prof. Dr. Dilantha Fernando from the University of Manitoba, in Canada, and Section Editor-in-Chief of Plants; Dr. Fermín Morales from Instituto de Agrobiotecnología (IdAB) – CSIC, in Spain; and Prof. Dr. Oscar Vicente from Universitat Politècnica de València (UPV) in Spain.

The conference brought plant scientists together to discuss innovations in sustainable agriculture, crop improvement, and environmental conservation.

With the global population projected to reach 9.7 billion by 2050, the conference addressed key challenges such as food security, climate change, and sustainable agroecosystems through keynote talks and seven specialized sessions.

The conference gathered 111 attendees from 36 different countries, featuring 1 keynote speaker, 9 invited speakers, and 41 selected talks, along with 56 posters. The event received just over 200 submissions and 102 accepted abstracts.

From insightful talks, engaging poster sessions and engaging networking moments, Plants 2025 was a special experience. You can relive the highlights from the Plants 2025 conference here with our after movie!


Awards

Four awards were presented at the conclusion of the conference, sponsored by the journal Plants: two Best Poster Awards (€250 each) and two Best Oral Presentation Awards (€300 each).

Plants 2025 Conference Team

The Plants 2025 Conference was organized by colleagues from MDPI’s Conference Team: Ana Sanchis (Conference Manager), Cédric Spinnler (Senior Conference Organizer), Raquel Sellès (Conference Organizer) and Laura Perez (Conference Assistant).

Upcoming event

5–7 May 2025
The 2nd International Electronic Conference on Metals
Location: Online event (Central European Summer Time)

As one of the pillar technologies that support the development of modern society and metallurgy, IECME 2025 will present the state-of-the-art of Metallurgy and Metals.

Find more upcoming MDPI events here.

Closing Thoughts

Swedish consortium renews partnership with MDPI

I’m pleased to share that MDPI has renewed its national partnership with Sweden’s Bibsam Consortium. This is a continued commitment to advancing open access publishing and supporting Sweden’s vision for fully open research.

Under this renewed agreement, 22 leading institutions including KTH Royal Institute of Technology, Stockholm University, Linnaeus University, and Linköping University, will continue to benefit from MDPI’s IOAP. This provides discounts on APCs and a more streamlined, researcher-friendly publishing experience.

MDPI and Bibsam renew national agreement for Sweden

“With robust backing from national open science guidelines, Sweden’s open-access landscape is rapidly advancing,” says Becky Castellon, institutional partnerships manager at MDPI.

“In fact, fewer than 15% of all Swedish research outputs were locked behind paywalls in 2023. We are passionate about the positive impact our ongoing partnership with the Bibsam Consortium will have on Swedish research, paving the way for ground-breaking developments and a more inclusive, open scientific community. Through flexible solutions and tailored policies, we enable institutions to prioritize research, foster innovation, and enhance accessibility, driving the shift to full open access.”

Recent MDPI IOAP Consortium signings from 2025:

  • The UK’s Jisc Consortium extended its national agreement, continuing support for more than 60 institutions across the UK.
  • Switzerland’s CSAL (Consortium of Swiss Academic Libraries) renewed its agreement, continuing our collaboration with top institutions such as ETH Zurich and EPFL Lausanne.
  • In Germany, we signed a new national agreement with ZB MED that includes over 100 universities and research institutions, with 78 institutions joining under a central or flat-fee model to simplify APC coverage.
Stefan Tochev
Chief Executive Officer
MDPI AG

30 April 2025
Announcing the Award Committee for the 2024 Tu Youyou Award

We are honored to introduce the award committee for the 2024 Tu Youyou Award, composed of distinguished scientists from around the world whose research covers diverse areas of natural product chemistry, pharmacognosy, and drug discovery. Their broad expertise and pioneering contributions have significantly advanced medicinal and natural products research.

Through their collective insights, rigorous evaluation, the committee has carefully selected this year’s award recipients, recognizing exceptional achievements in the field.

We sincerely thank these distinguished scholars for their efforts and dedication to upholding the standards of the Tu Youyou Award.  Below is the list of committee members. For more information about the Tu Youyou Award, please visit https://tuyouyouprize.org/

Chair:


Prof. Dr. A. Douglas Kinghorn
Ohio State University, USA
Prof. Dr. A. Douglas Kinghorn is a leading expert in pharmacognosy and natural products research. He is recognized for his key contributions to discovering bioactive compounds from plants, especially in anticancer, cancer chemopreventive, and substances with a sweet taste and taste-modifying agents. His prolific contributions include over 590 peer-reviewed works and book chapters and edited or co-edited 40 scientific volumes.
Committee Members:

Prof. Angelo Fontana
University of Naples “Federico II”, Italy
Angelo Fontana is a Professor of Organic Chemistry at the University of Naples “Federico II” in Italy and serves as Director of the Institute of Biomolecular Chemistry at the National Research Council (CNR). His research focuses on bioactive small molecules derived from marine eukaryotes, with a particular interest on their pharmaceutical applications in immunology and oncology. He also explores their potential as molecular tools for probing and modulating complex biological systems. Prof. Fontana is a co-founder of BioSEArch SRL and has been recognized with numerous grants and honors, including the Apivita Award from the Phytochemical Society of Europe.

Prof. Binghe Wang
Georgia State University, USA
Prof. Binghe Wang’s lab works on drug design, drug delivery, click chemistry, chemical biology, new diagnostics, and gaseous signaling molecules such as carbon monoxide and hydrogen sulfide. His interdisciplinary research supports advances in cancer, infectious diseases, organ protection, inflammation, and other areas.  

Dr. Diana Pinto
University of Aveiro, Portugal
Dr. Diana Pinto, an Associate Professor at the University of Aveiro, specializes in organic synthesis of bioactive heterocyclic compounds, sustainable catalysis (organo-, heterogeneous, and biocatalysis), and natural product research, including isolation, characterization, and total synthesis.

Prof. Hideaki Kakeya
Kyoto University, Japan
Prof. Hideaki Kakeya conducts cutting-edge research in chemical biology, high-throughput screening, and biosynthesis of bioactive natural products for system chemotherapy and other therapeutic applications.

Dr. RuAngelie Edrada-Ebel
University of Strathclyde, UK
Prof. RuAngelie Edrada-Ebel heads the Natural Products Metabolomics Group (NPMG), specializing in marine natural products discovery and metabolomics-driven drug development. A recognized expert in bioactive metabolites, she collaborates with industry and academia to address antimicrobial resistance and sustainable bioprospecting. She serves on the Editorial Board of Marine Drugs and holds two patents in the field.

Prof. Thomas Prisinzano
University of Kentucky, USA
Prof. Thomas Prisinzano combines medicinal and natural product chemistry to explore neurotransmitter systems and develop treatments for drug abuse and pain. He has received several prestigious awards, including the Innovator Award from the College on Problems of Drug Dependence.

Prof. Wei Li
University of Tennessee Health Science Center, USA
A distinguished professor and Director of the Drug Discovery Center, Prof. Wei Li is also the founder of SEAK Therapeutics, and the 2025 Chair-Elect of the Drug Discovery and Development Division of the American Society of Pharmacology and Experimental Therapeutics (ASPET). His work focuses on medicinal chemistry and small molecule drug discovery, with over 200 publications and 15 issued US patents.

30 April 2025
Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award


We are pleased to announce that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

2024 Tu Youyou Award Laureates

Richard DiMarchi
Indiana University, USA
Prof. Richard DiMarchi is a Distinguished Professor of Chemistry and Gill Chair in Biomolecular Sciences at Indiana University, USA. He is a member of the National Academy of Medicine and the National Inventors Hall of Fame. Dr. DiMarchi is a former Group Vice President at Eli Lilly and later at Novo Nordisk. He is recognized for his contributions to the discovery and development of rDNA-derived Humulin®, Humalog®, rGlucagon®, and Forteo®. His academic research has broadened the understanding of glucagon and incretin physiology and pioneered the discovery of single-molecule multi-mechanism agonists for the treatment of diabetes and obesity. The central element to success has been the chemical vision and technology to install within single molecules simultaneous agonism at related G-protein coupled receptors, coupled to the counter-intuitive discovery that glucagon and GIP agonism could synergize the therapeutic efficacy of GLP-1. These peptides and their conceptual approach have transformed the management of excessive body weight to a condition comparable to how hypertension, adult-onset diabetes, and excess cholesterol are medicinally managed.
Professor DiMarchi was recognized by the 2024 Tu Youyou Award Committee members as being an exceptional leader in the medicinal chemistry of peptides and proteins of natural origin, and as a pioneer in the field of chemical biotechnology. His very important discoveries have led to breakthroughs in new drugs related to the therapy of diabetes and obesity. He has been named as an inventor on a very large number of patents, and he has had initially a highly successful scientific and administrative career in industry, which was followed by over two decades in academia as a distinguished professor.
—Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee
   

Rolf Müller
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Germany;
Helmholtz Centre for Infections Research (HZI), Germany;
Saarland University, Germany
Prof. Rolf Müller is the Founding and Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Professor of Pharmaceutical Biotechnology at Saarland University, Germany. Having received his training from the University of Bonn, he held research positions at the University of Washington, USA, and Braunschweig University of Technology, Germany, prior to his appointment as professor to Saarland University. His laboratory has dedicated itself to the exploration of bacterial natural-product biosynthetic pathways for more than 20 years and has extensive experience in working with myxobacteria and other microbial producer strains. Starting from the isolation and characterization of new microorganisms, the scope of work includes microbiology-, biotechnology-, bioinformatics-, and chemistry-based approaches to exploit these isolates as sources of new drugs with a special focus on novel anti-infectives. Müller and his team apply a variety of state-of-the-art analytical methods and biological assays to perform biological and chemical characterizations of the identified compounds. Prof. Müller has received several awards, including the prestigious Gottfried Wilhelm Leibniz Prize, the PHOENIX Pharmacy Research Award, the DECHEMA Prize, and the Inhoffen Medal, as well as being an elected member of acatech, Leopoldina, and the German Academy of Sciences and Literature.
The 2024 Tu Youyou Award Committee members were highly impressed by the truly outstanding past and ongoing contributions of Professor Müller in both microbial natural products isolation chemistry and in biosynthesis, as well as in the development of lead compounds for their potential in treating human diseases, through his global connections with various major funding agencies. He is also a dedicated teacher who has trained numerous graduate students and postdoctoral fellows, and he has lectured on his research in countries all over the world.
—Prof. Dr. A. Douglas Kinghorn, Chair of the Award Committee

The achievements of Richard DiMarchi and Rolf Müller highlight the transformative impact of natural products chemistry and medicinal chemistry. We congratulate them and invite the global academic community and public to join us in celebrating their significant contributions.

2024 Award Committee
Committee Chair:

Committee Members (listed in alphabetical order):

  • Prof. Angelo Fontana, University of Naples “Federico II”, Italy;
  • Prof. Binghe Wang, Georgia State University, USA;
  • Dr. Diana Pinto, University of Aveiro, Portugal;
  • Prof. Hideaki Kakeya, Kyoto University, Japan;
  • Dr. RuAngelie Edrada-Ebel, University of Strathclyde, UK;
  • Prof. Thomas Prisinzano, University of Kentucky, USA
  • Prof. Wei Li, University of Tennessee Health Science Center, USA.

About the Tu Youyou Award:
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honor the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award honoring exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.

Back to TopTop